New NPC Analysis Illustrates How IRA’s Medicare Drug Price Negotiation Program May Reshape Pharmaceutical R&D Incentives
Study signals IRA’s widespread potential effects for long-term innovation incentives across disease states & disproportionate impact on small molecule drugs. WASHINGTON, DC, UNITED STATES, October 16, 2025 /EINPresswire.com/ -- A new …